-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

SCI-30 Germline and Somatic Genomics in Ribosomopathies

Program: Scientific Program
Session: Precision Medicine Approaches to Leukemia Predisposition in Bone Marrow Failure
Hematology Disease Topics & Pathways:
AML, HSCs, Adult, Diseases, Bone Marrow Failure, Genetic Disorders, MDS, Pediatric, Biological Processes, Technology and Procedures, Young Adult, Cell Lineage, Study Population, Myeloid Malignancies, genomics, genetic profiling, Clinically relevant, hematopoiesis, molecular testing, NGS, pathogenesis
Monday, December 7, 2020, 11:25 AM-11:30 AM

R. Coleman Lindsley, MD, PhD

Dana-Farber Cancer Institute, Boston, MA

Disclosures: Lindsley: Bluebird Bio: Consultancy; Takeda Pharmaceuticals: Consultancy; MedImmune: Research Funding; Jazz Pharmaceuticals: Consultancy, Research Funding.